Article Details

Casma Therapeutics Raises $58.5M in Series A Funding

Retrieved on: 2018-05-03 00:07:30

Tags for this article:

Click the tags to see associated articles and topics

Casma Therapeutics Raises $58.5M in Series A Funding. View article details on hiswai:

Excerpt

<div>Casma Therapeutics, Inc., a Cambridge, MA-based biotechnology company harnessing the natural cellular process of autophagy to design new medicines, raised $58.5m in Series A funding. <b>Third Rock Ventures</b> made the investment. Launched in 2018 by Keith Dionne, Ph.D., chief executive officer, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up